Medical Pearl: Pneumocystis pneumonia prophylaxis for patients on chronic systemic corticosteroids

Journal of the American Academy of Dermatology

Volumn 55, Issue 1, 2006, Pages 124-125

  Lemaire, Chad M ^a   Browning, John C ^a   Hsu, Sylvia ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; COTRIMOXAZOLE; DAPSONE; PENTAMIDINE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CORTICOSTEROID THERAPY; DRUG COST; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG MONITORING; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION PREVENTION; OXYGEN THERAPY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; TREATMENT CONTRAINDICATION;

ADRENAL CORTEX HORMONES; HUMANS; PNEUMONIA, PNEUMOCYSTIS;

EID: 33744993449     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.11.1054     Document Type: Article

References (14)

1. Morris A., Lundgren J.D., Masur H., Walzer P.D., Hanson D.L., Frederick T., et al. Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 10 (2004) 1713-1720
2. Gluck T., Geerdes-Fenge H.F., Straub R.H., Raffenberg M., Lang B., Lode H., et al. Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy. Infection 28 (2000) 227-230
3. Rencic A., Caeiro J.P., Hernandez M.I., and Nousari H.C. Prophylaxis in dermatologic patients receiving immunosuppressive therapy. Dermatol Ther 15 (2002) 352
4. Sepkowitz K.A. Pneumocystis carinii pneumonia in patients without AIDS. Clin Infect Dis 17 Suppl 2 (1993) S416-S422
5. Pareja J.G., Garland R., and Koziel H. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 113 (1998) 1215-1224
6. Ly H.T., Thermidor M., and Cunha B.A. Pneumocystis carinii pneumonia in a non-HIV patient on steroids. Heart Lung 33 (2004) 261-264
7. Abernathy-Carver K.J., Fan L.L., Boguniewicz M., Larsen G.L., and Leung D.Y. Legionella and Pneumocystis pneumonias in asthmatic children on high doses of systemic steroids. Pediatr Pulmonol 19 (1995) 398
8. Aviles R., Boyce T.G., and Thompson D.M. Pneumocystis carinii pneumonia in a 3-month-old infant receiving high-dose corticosteroid therapy for airway hemangiomas. Mayo Clin Proc 79 (2004) 243-245
9. Raychaudhuri S.P., and Siu S. Pneumocystis carinii pneumonia in patients receiving immunosuppressive drugs for dermatological diseases. Br J Dermatol 141 (1999) 528-530
10. Yale S.H., and Limper A.H. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 71 (1996) 5-13
11. Thomas Jr. C.F., and Limper A.H. Pneumocystis pneumonia. N Engl J Med 350 (2004) 2487-2498
12. Rodriguez M., and Fishman J.A. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev 17 (2004) 770-782
13. Kaplan J.E., Masur H., and Holmes K.K. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 51 RR-8 (2002) 1-52
14. Drugstore.com Website. Price information for 30 tablets of double-strength trimethoprim-sulfamethoxazole. Available at: http://www.drugstore.com/pharmacy/prices/drugprice.asp?ndc=00364206905&trx=1Z5006. Accessed: January 31, 2006.